Literature DB >> 8262917

Functional expression and properties of the tRNA(Lys)-specific core anticodon nuclease encoded by Escherichia coli prrC.

I Morad1, D Chapman-Shimshoni, M Amitsur, G Kaufmann.   

Abstract

Escherichia coli carrying the optional locus prr harbor a latent, tRNA(Lys)-specific anticodon nuclease, activated by the product of phage T4 stp. Anticodon nuclease latency is ascribed to the masking of prrC, implicated with the enzymatic activity, by flanking, type Ic DNA restriction modification genes (prrA, B&D-hsdM, S&R). Overexpression of plasmid-borne prrC elicited anticodon nuclease activity in uninfected E. coli. In vitro, the prr-C-coded core activity was indifferent to a synthetic Stp polypeptide, GTP, ATP, and endogenous DNA, effectors that synergistically activate the latent enzyme. Several facts suggested that PrrC is highly labile in the absence of the masking proteins. The core activity decayed with t1/2 below 1 min at 30 degrees C, and the PrrC portion of a fusion protein was unstable. Moreover, expression of prrC from its own promoter at low plasmid copy number did not allow detection of core activity. Yet, it sufficed for establishment of a latent, T4-inducible enzyme when complemented by the masking Hsd proteins, which were provided by another replicon. Interaction between the antagonistic components of latent anticodon nuclease was also demonstrated immunochemically. The coupling of anticodon nuclease with a DNA restriction modification system may serve to ward off its inadvertent toxicity and maintain it as an antiviral contingency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262917

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The transition from noncoded to coded protein synthesis: did coding mRNAs arise from stability-enhancing binding partners to tRNA?

Authors:  Harold Stephen Bernhardt; Warren Perry Tate
Journal:  Biol Direct       Date:  2010-04-09       Impact factor: 4.540

Review 2.  The phage-host arms race: shaping the evolution of microbes.

Authors:  Adi Stern; Rotem Sorek
Journal:  Bioessays       Date:  2011-01       Impact factor: 4.345

3.  Cleavage of the HIV replication primer tRNALys,3 in human cells expressing bacterial anticodon nuclease.

Authors:  N Shterman; O Elroy-Stein; I Morad; M Amitsur; G Kaufmann
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

Review 4.  Post-transcriptional control by bacteriophage T4: mRNA decay and inhibition of translation initiation.

Authors:  Marc Uzan; Eric S Miller
Journal:  Virol J       Date:  2010-12-03       Impact factor: 4.099

5.  PrrC-anticodon nuclease: functional organization of a prototypical bacterial restriction RNase.

Authors:  Shani Blanga-Kanfi; Michal Amitsur; Abdussalam Azem; Gabriel Kaufmann
Journal:  Nucleic Acids Res       Date:  2006-06-21       Impact factor: 16.971

6.  Reconstitution and structure of a bacterial Pnkp1-Rnl-Hen1 RNA repair complex.

Authors:  Pei Wang; Kiruthika Selvadurai; Raven H Huang
Journal:  Nat Commun       Date:  2015-04-17       Impact factor: 14.919

Review 7.  Generation of 2',3'-Cyclic Phosphate-Containing RNAs as a Hidden Layer of the Transcriptome.

Authors:  Megumi Shigematsu; Takuya Kawamura; Yohei Kirino
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

8.  RloC: a wobble nucleotide-excising and zinc-responsive bacterial tRNase.

Authors:  Elena Davidov; Gabriel Kaufmann
Journal:  Mol Microbiol       Date:  2008-08-04       Impact factor: 3.501

Review 9.  Transfer RNA-Derived Fragments, the Underappreciated Regulatory Small RNAs in Microbial Pathogenesis.

Authors:  Zhongyou Li; Bruce A Stanton
Journal:  Front Microbiol       Date:  2021-05-17       Impact factor: 5.640

10.  Parallel dimerization of a PrrC-anticodon nuclease region implicated in tRNALys recognition.

Authors:  Daniel Klaiman; Michal Amitsur; Shani Blanga-Kanfi; Michal Chai; Darrell R Davis; Gabriel Kaufmann
Journal:  Nucleic Acids Res       Date:  2007-06-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.